Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease

Indian Journal of Ophthalmology

Volumn 52, Issue 2, 2004, Pages 139-144

  Rajesh, Mohanraj ^a   Sulochana, Konerirajapuram N ^a   Coral, Karunakaran ^a   Punitham, Ranganathan ^a   Biswas, Joytirmay ^a   Babu, Kalpana ^a   Ramakrishnan, S ^a,b  

^a Sankara Nethralaya ^*  (India)

^b VISION RESEARCH FOUNDATION   (India)

Author keywords

Antioxidants; Eales' disease; Lipid peroxidation; Oxidative stress; Protein carbonyl groups

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; FREE RADICAL; GLUTATHIONE; PLASMA PROTEIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EALES DISEASE; ENZYME ACTIVITY; HUMAN; IDIOPATHIC DISEASE; INFLAMMATORY DISEASE; MALE; MONITOR; RETINA VASCULITIS; TISSUE INJURY;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; ERYTHROCYTES; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RETINAL VASCULITIS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 3142698374     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ames BN, Shigena MK, Hagen TM. Oxidants, antioxidants and degenerative diseases of aging. Proc Natl Acad Sci U.S.A. 1991;90:7915-22.
2. Corss OE, Halliwell B, Borish ET, Pyror W, Ames BN, Saul RL et al. Oxygen radicals and human disease. Ann Intern Med. 1987;107:526-45.
3. Morris CJ, Earl JS, Treham CW, Blank DR. Reactive oxygen species and iron: a dangerous partnership in inflammation. Int J Biochem Cell Biol 1995;27:109-22.
4. Sanhga O, Stucki G. Vitamin E therapy for rheumatic diseases. Rheumatol 1998;57:207-14.
5. Cuzzocrea S, Riley PD, Caputi PA, Salvemini. Antioxidant therapy: A new pharmacological approach in shock, inflammation and ischemia/reperfusion injury. Pharmcol Rev. 2001;53:165-69.
6. Eales H. Retinal hemorrhages associated with epistaxis and constipation. Brim Med Rev 1880;9:262-65.
7. Puttamma ST. Varied fundus picture of peripheral retinal vasculitis. Trans Asia Pacific Acad Ophthalmol 1970;3:520-25.
8. Biswas J, Sharma T, Gopal L, Madhavan HN, Sulochana KN, Ramakrishnan S. Eales' Disease-an update. Surv Ophthalmol. 2002;47:1-18.
9. Garibaldi S, Argno I, Odetti P, Marinari UN. Relationships between protein carbonyls, retinol and tocopherol level in human plasma. Biochem Molec Biol Int. 1994;36:729-36.
10. Stadtman ER, Levine RL. Protein Oxidation. Ann New York Acad Sci 2000;889:191-208.
11. Stadtman ER, Strakeread PE, Oliver CN, Carney JM, Floyd, RD. Protein modification in aging. EXS. 1992;62:64-72.
12. Petropoules L, Conconi M, Cong X, Hoenel B, Bregegere F, Milner Y, Friguet B. Increase of oxidatively modified proteins is associated with decrease in proteasome activity in aging epidermal cells. J Gerentol A Biol Sci Med Sci 2000;55:220-27.
13. Devein M, Berenstein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as marker for oxidative damage. Free Rad Res 2000;33:S99-108.
14. Hopp RG, Ravendi A, Herrara D, Kukis A, Hoff HF. Oxidation products of cholesteryl esters are resistant to hydrolysis to macrophages, form complexes with proteins and are present in human atherosclerotic lesions. J Lipid Res 1997;38:1347-60.
15. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990;186:464-78.
16. Lowry OH, Roseberg NJ, Farr AL, Randell RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-75.
17. Miao-Lin Hu. Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol 1994;233:381-85.
18. Misra HP, Firdovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-75.
19. Devasagayam PA, Tarachand V. Decrease in lipid peroxidation in the rat kidney during gestation. Biochem Biophy Res Commun. 1987;145:134-38.
20. Rose RC, Richer SP, Bode AM. Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med 1998;217:397-407.
21. Rao NA, Wu GS. Free radical mediated photoreceptor damage in uveitis. Prog Ret Eye Res 2000;19:41-68.
22. Adler FH. In Physiology of the Eye, 9th ed. St. Louis: CV Mosby; 1990. p 586.
23. Forrest GL, Futterman S. Age related changes in the retinal capillaries and fatty acid composition of retinal tissue from normal and fatty acid deficient rats. Invest Ophthalmol Vis Sci 1972;11:760-64.
24. Jose MM, Gomez CP, De Castro NI. Antioxidant enzymes and human diseases. Clin Biochem. 1999;32:595-603.
25. Thomas EL, Learn DB, Jefferson MM, Weatherred W. Superoxide dependent oxidation of extracellular reducing agents by isolated phagocytes. J Biol Chem 1988;263:2178-86.
26. Bhooma V, Sulochana KN, Biswas J, Ramakrishnan S. Eales' disease: Accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Curr Eye Res 1997;16:91-95.
27. Sulochana KN, Biswas J, Ramakrishnan S. Eales' disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous. Curr Eye Res 1999;18:254-59.
28. Srivatsava P, Saxena S, Khanna KV, Kumar D, Nath R, Seth KP. Raised platelet thiobarbituric acid reacting substances in proliferative Eales' disease. Indian J Ophthalmol 2000;48:307-9.
29. Saxena S, Kumar D, Srivatsava P, Khanna VK, Seth PK. Low levels of platelet glutathione in Eales' disease. Med Sci Res 1999;27:625-26.
30. Refgaard FHH, Tasi H, Stadtman ER. Modification of protein by unsaturated fatty acid peroxidation products. Proc Natl Acad Sci. U.S.A. 2000;97:611-16.
31. Stadtman ER. Metal catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Rad Biol Med 1990;9:315-25.
32. Moskovitz J, Yim B, Chock B. Free radicals and diseases. Arch Biochem Biophys. 2002;397:354-60.
33. Lightman S, Greenwood J. Effect of lymphocytic infiltration in the blood-retinal barrier in experimental autoimmune uveitis. Clin Exp Immunol. 1992;88:473-77.
34. Marnett LJ, Riggins JN, West JD. Endogenous generation of reactive oxidants and electrophils and their reactions with DNA and protein. J Clin Invest 2003;111:533-93.
35. Miyata T, Kurukama K, Strikaw CUY. Advanced glycation and lipid oxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 2000;11;1749-52.
36. Stitt AW. Advanced glycation: an important event in diabetic and age related ocular diseases. Br J Ophthalmol 2001;85:746-53.
37. Swamy MS, Coral K, Krishnakumar S, Biswas J, Ramakrishnan S, Nagaraj RH, Sulochana KN. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: A possible role in ocular neovascularization. Curr Eye Res 2002;36:139-45.
38. Smith MA, Sayre VE, Anderson PL, Harris MF, Kowall N, Perry G. Cytochemical demonstration of oxidative damage in Alzheimer's disease by immunochemical enhancement of the carbonyl reaction with 2,4 dinitrophenylhydrzine. J Histochem Cytochem 1998;46:731-35.
39. Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997;69:1326-29.
40. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
41. Renke J, Popadiuk S, Korzon M, Bugaicyzk, Wozniak M. Protein carbonyl groups content as a usual clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Rad Biol Med 2000;29:101-4.
42. Murphy ME, Keher JP. Oxidation state of tissue thiol group and content of protein carbonyl groups in chickens with inherited muscular dystrophy. Biochem J 1989; 260:359-64.
43. Garland D, Russell P, Zigler JS. Oxidative modifications of lens proteins. Simic MG, Taylor KS, Ward JF, Von Stontag, editors. Oxygen Radicals in Biology and Medicine. New York: Plenium; 1988. pp 347-53.
44. Uchida K, Fukuda S, Kawakishi S, Hiai H, Toyokuni S. A renal carcinogen ferric nitroacetate mediates a temporary accumulation of aldehyde modified proteins within cytosolic compartemtnt of rat kidney. Arch Biochem Biophys 1995;317:405-11.
45. Odetti P, Garibaldi S, Gurrei G, Argano I, Dapino D, Pronzato NA. Protein oxidation in hemodialysis and kidney transplantation. Metabolism. 1996;45:1319-1322.
46. Gladstone IM, Levine RL. Oxidation of proteins in neonatal lungs. Pediatrics 1994;93:764-68.
47. Bowling AC, Schulz JB, Brown RH, Beal MF. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amylotrophic lateral sclerosis. J Neurochem 1993;61:2322-25.
48. Rooji VJ, Sicco GWS, Mulder GHP, Baarsma GS. Oral vitamins C and E as additional treatment with acute anterior uveitis: A randomized double masked study in 145 patients. Br J Ophthalmol 1999;83:1277-82.
49. Mc Call MR, Feri B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Rad Biol Med 1999;26:1034-53.